Ongoing Fundings

Ongoing Fundings

Grant Type
Project Title
Amount
Start Date
Completion Date
Principal Investigator
Area of Excellence (AoE/M-707/18)
Institute of Metabolic Medicine
77,803,000.00
01/05/2019
30/04/2027
Prof. Aimin XU
GRF (17117320)
The mechano-sensitive ion channel Piezo1 balances the conversion of mesenchymal stem cells to osteoblasts and bone marrow adipocytes
1,195,542.00
01/01/2021
31/12/2023
Prof. Aimin XU
E-HKU703/20
Targeting Gut Microbiota for Non-alcoholic Fatty Liver Disease
1,691,843.00
01/10/2020
31/08/2020
Prof. Aimin XU
GRF (17121819)
The Single Transmembrane Protein β-klotho as a Novel Regulator of Insulin Secretion in Pancreatic β-cells
1,684,895.00
01/01/2020
31/12/2022
Prof. Aimin XU
HMRF (06172446)
Autotaxin as a potential mediator of obesity-related metabolic complications
1,496,996.00
15/07/2019
14/07/2022
Prof. Aimin XU
Platform Technology Funding (PTF)
An advanced monoclonal antibody platform for biopharmaceutical development, medical diagnosis and precision medicine
723,115.00
30/06/2019
29/06/2021
Prof. Aimin XU
RGF (1233576)
Roles of FGF21 signaling pathways in conferring the beneficial effects of physical exercise on cardiac metabolism and function in diabetic hearts
445,157.67
01/01/2019
31/12/2021
Prof. Aimin XU
GRF (17124420)
Adiponectin-expressing thymic Treg for adoptive immunotherapy in obesity and metabolic diseases
17,124,420.00
01/08/2020
31/07/2023
Dr. Yu WANG
GRF (17124718)
Endothelial SIRT1 - a key circadian regulator controlling the 24-hour rhythmicity in blood pressure and energy metabolism
1,486,164.00
01/01/2019
31/12/2021
Dr. Yu WANG
GRF (17101819)
Syndecan-4 (Sdc4) as a key regulator of white adipose tissue browning for energy expenditure
1,113,341.00
01/01/2020
31/12/2022
Dr. Ruby Lai Chong HOO
HMRF (06172646)
Mitochondrial protein coiled-coil-helix-coiled-coil-helix domain 10 (Chchd10) as a novel factor for the treatment of obesity and its related diseases
982,396.00
01/06/2019
31/05/2021
Dr. Ruby Lai Chong HOO
GRF (17105318)
Neutrophil serine proteases as the endogenous suppressors of white adipose tissue browning and adaptive thermogenesis
775,656.00
01/01/2019
31/12/2021
Dr. Ruby Lai Chong HOO
Guangdong-Hong Kong Technology Cooperation Funding Scheme
Development and Preclinical Evaluation of a A-FABP Neutralizing Monoclonal Antibody for Ischemic Stroke Treatment
1,327,458.00
01/09/2019
31/08/2021
Dr. Ruby Lai Chong HOO
GRF (17121520)
Androgen regulates white adipose tissue remodelling via suppression of PRDM16
1,145,727.00
01/01/2021
31/12/2023
Dr. Xiaoyan HUI
NSFC Young Excellent Scientist fund
Mechanistic study of adipose browning
1,300,00.00 (RMB)
01/01/2020
01/01/2020
Dr. Xiaoyan HUI
GRF (17123419)
Thyroid hormone induces facultative thermogenesis in white adipose tissue through UCP1-independent mechanism
957,916.00
01/10/2019
30/09/2022
Dr. Xiaoyan HUI
HMRF (06172346)
AMPK γ2 as a master regulator of adipokine transcription: biological function, molecular mechanism and clinical implications
1,449,248.00
16/09/2019
15/09/2022
Dr. Xiaoyan HUI
HMRF (17123718)
Deletion of Telomere-Rap1 increases the susceptibility to myocardial ischemia/reperfusion injury via p53-PGC1α signaling during aging
868,463.00
01/01/2019
31/12/2021
Dr. Zhengyuan XIA
GRF (06173456)
Development of ultrasound-responsive polymeric nanoreactors for retinoblastoma therapy
1,499,628.00
01/08/2019
31/07/2022
Dr. Weiping WANG
HMRF (81803769)
Hydrogen sulfide-responsive small-molecule nanoparticles as drug delivery carriers for cancer therapy and diagnosis
263,760.00
01/01/2019
31/12/2021
Dr. Weiping WANG
HMRF (06172266)
Exploring the role of microRNA in sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes
1,499,956.00
01/08/2019
31/07/2022
Dr. Yu Yan CHEUNG
HMRF (06172636)
Targeting G protein-coupled receptor 110 for the treatment of obesity and non-alcoholic fatty liver disease
1,399,248.00
01/05/2019
30/04/2022
Dr. Zhe HUANG